The trial was prospectively registered on ClinicalTrials.gov ( NCT02814409 ). Findings Between Jan 25, 2017, and May 30, 2023, 1858 patients were randomly assigned to a treatment group, of whom 1777 received thrombolytic treatment and were included in the modified intention-to-treat population (...